NuVasive, Inc. (NASDAQ:NUVA)

nerdboyjeff (47.62) Submitted: 11/28/2007 12:26:42 PM : Start Price: $42.04 NUVA Score: -49.21

Good spine company building business, taking market share in a growing business. Good buyout target from one of the big boys like JNJ or MDT.

DrQuay (84.93) Submitted: 11/23/2007 9:02:20 AM : Start Price: $39.35 NUVA Score: -48.15

Triple AAA stock to have in your portfolio.
Stock price keeps growing & growing like ever-ready bunny!

Zenoak (60.37) Submitted: 10/10/2007 3:11:35 PM : Start Price: $36.79 NUVA Score: -36.61

This company is gowing at a 50% rate and should turn profitable in the 3rd quarter. It could be another ISRG only dealing with the spine.

vkrish98 (66.06) Submitted: 10/8/2007 12:30:22 PM : Start Price: $35.87 NUVA Score: -36.05

Company revenues up 96% for last 3 years. THis could be the next intutive surgical.

snapperreef (64.33) Submitted: 9/19/2007 12:32:27 PM : Start Price: $35.19 NUVA Score: -36.23

NuVasive, Inc. designs, develops, and markets products for the surgical treatment of disorders of the spine, focusing mainly on spinal fusion. It features a minimally invasive surgical platform called Maximum Access Surgery (MAS), which uses a software-driven nerve
avoidance system called NeuroVision, and MaXcess, a retraction system that allows for smaller incisions compared to open surgical techniques.
2003 2004 2005 2006 2007
Revenues ($mill) 22.7 38.4 61.8 98.1 145

and 0 debt.

CumberlandRidge (< 20) Submitted: 5/25/2007 11:26:02 AM : Start Price: $25.45 NUVA Score: -16.93

I have played this story before and money each time. Now I want to hold longer as this company is really coming together in its model. They have a fantastic medical techology platform for back surgery. Could be a take at some point in the next couple of years.

joewhite101 (51.12) Submitted: 9/22/2006 9:36:21 PM : Start Price: $19.02 NUVA Score: -5.91

Strong growth potential for medical devices and procedures for back surgery that are less invasive. Many big name backers